Cough drops are available over the counter, but they can be packed with sugar and contain ingredients with potentially ...

Shares of Lenz Therapeutics (LENZ) dropped after a case of retinal tear surfaced inn the FDA’s adverse-event database known as FAERS. The company, ...

Investing.com -- LENZ Therapeutics (NASDAQ:LENZ) stock tumbled 25% on heavy volume Friday in New York after a case of retinal tear associated with its VIZZ eye drop appeared in the FDA’s adverse event ...

Biotech stock Harrow is in a cup base with a buy point of 50.72 after third-quarter results.

LENZ Therapeutics' newly approved presbyopia drop sits in a category with only one real commercial predecessor—AbbVie’s Vuity ...

For this study, researchers recruited 766 participants diagnosed with presbyopia. Participants were treated with the pilocarpine-diclofenac eye drops at three different percentages of pilocarpine — 1% ...

Researchers estimate that about 1.8 billion people around the world live with presbyopia, a farsightedness condition that can appear as a person grows older. More recent treatment options for ...

Share on Pinterest Scientists have developed new eye drops that could help with presbyopia. Ekaterina Vasileva-Bagler/Getty Images Researchers estimate that about 1.8 billion people around the world ...

New presbyopia-correcting eye drops, including VIZZ and Qlosi, offer alternatives to Vuity, with more options under FDA review. Efficacy is measured by improvements in near vision, with new drops ...

The FDA approved aceclidine 1.44% ophthalmic solution (Vizz) for adults with presbyopia, or age-related blurred near vision, maker Lenz Therapeutics announced on Thursday. It marks the first ...

Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine eye drop to crack the large presbyopia market, where past efforts by other drug developers have mostly been unsuccessful. The ...

LENZ Therapeutics, Inc.'s LNZ100 eye drop shows promising results for presbyopia, with strong phase 3 data and potential FDA approval by August 2025. LNZ100 demonstrated superior efficacy compared to ...